MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
πŸ‡¨πŸ‡³China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Colon Neoadjuvant FOLFOXIRI Study

Phase 2
Active, not recruiting
Conditions
Rectal Cancer
Interventions
Drug: neoadjuvant FOLFOXIRI
Drug: Capecitabine
First Posted Date
2013-09-13
Last Posted Date
2024-06-24
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
40
Registration Number
NCT01941641
Locations
πŸ‡­πŸ‡°

Department of Clinical Oncology, Hong Kong, Hong Kong

ATOM_local Ablative Therapy

Phase 2
Completed
Conditions
Activating EGFR Mutation
NSCLC
Interventions
Radiation: preemptive local ablative therapy
Drug: Oral TKI
First Posted Date
2013-09-13
Last Posted Date
2020-06-18
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
18
Registration Number
NCT01941654
Locations
πŸ‡­πŸ‡°

Department of Clinical Oncology, Hong Kong, Hong Kong

Safety & Effectiveness of Nurse Performed Colonoscopies Under Supervision

Not Applicable
Completed
Conditions
Colorectal Cancer
Interventions
Procedure: Colonoscopy
First Posted Date
2013-08-15
Last Posted Date
2013-08-15
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
731
Registration Number
NCT01923155
Locations
πŸ‡­πŸ‡°

Combined Endoscopy Unit, Alice Ho Miu Ling Nethersole Hospital, Tai Po, Hong Kong

A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir

Not Applicable
Completed
Conditions
Chronic Heptitis B
Interventions
First Posted Date
2013-08-08
Last Posted Date
2017-07-19
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
36
Registration Number
NCT01918631
Locations
πŸ‡­πŸ‡°

Prince of Wales Hospital, Hong Kong, Hong Kong

Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients

Not Applicable
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Sleep education
First Posted Date
2013-06-20
Last Posted Date
2013-06-20
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
264
Registration Number
NCT01881724
Locations
πŸ‡­πŸ‡°

Clinical Trial Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong

πŸ‡¨πŸ‡³

The Chinese University of Hong Kong, Hong Kong, China

Electroacupuncture for Postoperative Ileus After Laparoscopic Rectal Cancer Surgery

Not Applicable
Conditions
Postoperative Ileus
Interventions
Procedure: Electroacupuncture
First Posted Date
2013-05-03
Last Posted Date
2014-02-11
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
50
Registration Number
NCT01844908
Locations
πŸ‡¨πŸ‡³

Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma
Interventions
Procedure: TEA
First Posted Date
2013-04-23
Last Posted Date
2019-09-03
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
200
Registration Number
NCT01837381
Locations
πŸ‡­πŸ‡°

Department of Clinicl Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

πŸ‡­πŸ‡°

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinsese University of Hong Kong, Hong Kong, Hong Kong

πŸ‡­πŸ‡°

Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids

Not Applicable
Terminated
Conditions
Uterine Fibroids
Interventions
Procedure: UAE
Procedure: HIFU
First Posted Date
2013-04-18
Last Posted Date
2019-08-30
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
85
Registration Number
NCT01834703
Locations
πŸ‡­πŸ‡°

Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong

πŸ‡­πŸ‡°

Department of Obstectrics and Gynaecology, Prince of Wales Hospital, Hong Kong, Hong Kong

Cetuximab Rechallenge Study

Phase 2
Completed
Conditions
Metastatic Colorectal Cancer
Interventions
Drug: cetuximab-containing chemotherapy
First Posted Date
2013-04-16
Last Posted Date
2020-06-18
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
17
Registration Number
NCT01832467
Locations
πŸ‡­πŸ‡°

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Effects of CPAP on Visceral Fat Thickness

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: CPAP
First Posted Date
2013-04-10
Last Posted Date
2015-11-16
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
141
Registration Number
NCT01828281
Locations
πŸ‡¨πŸ‡³

Respiratory Division, Hong Kong, China

Β© Copyright 2025. All Rights Reserved by MedPath